These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 6219886

  • 21. Long-term complete autologous reconstitution following cyclophosphamide and allogeneic marrow infusion in a case of severe aplastic anemia.
    Bussel A, Dumont J, Schenmetzler C, Seger J, Marcelli-Barge A, Hors J.
    Nouv Rev Fr Hematol (1978); 1985; 27(1):15-8. PubMed ID: 3887328
    [Abstract] [Full Text] [Related]

  • 22. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
    Tsoi MS, Storb R, Weiden PL, Thomas ED.
    J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
    [Abstract] [Full Text] [Related]

  • 23. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party.
    Bacigalupo A, Hows J, Gordon-Smith EC, Gluckman E, Van Lint MT, Congiu M, James DC, Barrett AJ, Gmur J, De Planque MM.
    Bone Marrow Transplant; 1988 Nov; 3(6):531-5. PubMed ID: 3063321
    [Abstract] [Full Text] [Related]

  • 24. Bone marrow transplantation in 65 patients with severe aplastic anemia.
    Gluckman E, Devergie A, Gerotta I, Hors J, Sasportes M, Boiron M, Bernard J.
    Bull Cancer; 1981 Nov; 68(1):74-7. PubMed ID: 7013871
    [Abstract] [Full Text] [Related]

  • 25. Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?
    Storb R, Prentice RL, Banaji M, Witherspoon RP, Sullivan KM, Stewart P, Sanders JE, Mason M, Doney K, Deeg J, Clift RA, Buckner CD, Appelbaum FR, Thomas ED.
    Blood; 1983 Apr; 61(4):672-5. PubMed ID: 6338970
    [Abstract] [Full Text] [Related]

  • 26. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
    Xue HM, Xu HG, Huang K, Guo HX, Li Y, Zhou DH, Huang SL, Fang JP, Chen C.
    Genet Mol Res; 2015 May 18; 14(2):5234-45. PubMed ID: 26125718
    [Abstract] [Full Text] [Related]

  • 27. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience.
    Wagner JL, Deeg HJ, Seidel K, Anasetti C, Doney K, Sanders J, Sullivan KM, Storb R.
    Transplantation; 1996 Jan 15; 61(1):54-61. PubMed ID: 8560574
    [Abstract] [Full Text] [Related]

  • 28. Editorial: Bone-marrow grafting for aplastic anaemia.
    Lancet; 1975 Jan 04; 1(7897):22-3. PubMed ID: 46340
    [No Abstract] [Full Text] [Related]

  • 29. Bone marrow transplantation experience for children with aplastic anemia.
    Sanders JE, Whitehead J, Storb R, Buckner CD, Clift RA, Mickelson E, Appelbaum FR, Bensinger WI, Stewart PS, Doney K.
    Pediatrics; 1986 Feb 04; 77(2):179-86. PubMed ID: 3511444
    [Abstract] [Full Text] [Related]

  • 30. Cytotoxicity against HLA-identical sibling lymphocytes: genetic determination and independent segregation of the antigenic system involved.
    Warren RP, Storb R, Weiden PL, Su PJ, Thomas ED.
    Transplant Proc; 1978 Mar 04; 10(1):67-9. PubMed ID: 345567
    [No Abstract] [Full Text] [Related]

  • 31. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
    Hamblin M, Marsh JC, Lawler M, McCann SR, Wickham N, Dunlop L, Ball S, Davies EG, Hale G, Waldmann H, Gordon-Smith EC.
    Bone Marrow Transplant; 1996 May 04; 17(5):819-24. PubMed ID: 8733704
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Possible role of lymphocyte cytotoxicity in bone-marrow grafting.
    Oldham RK, Simmler MC.
    Transplant Proc; 1974 Dec 04; 6(4):417-9. PubMed ID: 4280166
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Studies of the response in mixed leukocyte culture of cells from patients with aplastic anemia to cells from HLA-identical siblings.
    Mickelson EM, Clift RA, Fefer A, Storb R, Thomas ED, Warren RP, Hansen JA.
    Transplantation; 1981 Aug 04; 32(2):90-5. PubMed ID: 6457424
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.
    Kaminski E, Hows J, Man S, Brookes P, Mackinnon S, Hughes T, Avakian O, Goldman JM, Batchelor JR.
    Transplantation; 1989 Oct 04; 48(4):608-13. PubMed ID: 2508280
    [Abstract] [Full Text] [Related]

  • 39. [The human bone marrow transplant. II. The transplant in aplastic anemia].
    Izzi T, Lucarelli G.
    Recenti Prog Med; 1983 Feb 04; 74(2):199-213. PubMed ID: 6346419
    [No Abstract] [Full Text] [Related]

  • 40. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG.
    Rev Invest Clin; 2005 Feb 04; 57(2):298-304. PubMed ID: 16524071
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.